Industry

Studies utilizing Gemelli’s proprietary diagnostic technologies demonstrate key clinical applications, advancements in IBS and SIBO diagnostics, and treatment support. These findings will be presented at Digestive Disease Week® 2026 (May 2-5), reflecting the increasing adoption of 3-gas breath and antibody testing. RALEIGH, N.C.–(BUSINESS WIRE)–Gemelli Biotech announced today that its diagnostic technologies will be featured across … [Read more…]

New Paubox research finds healthcare IT leaders confident in their defenses while encryption gaps drive breaches across the industry. SAN FRANCISCO–(BUSINESS WIRE)–#PHI–Healthcare IT leaders are giving themselves top marks on email breach detection while their organizations keep getting breached, according to new research from Paubox. In a survey of 170 U.S. healthcare IT leaders, 100% … [Read more…]

Food Allergy Fund Debuts Caregiver resource with Dr. Becky Kennedy, alongside breakthroughs in food allergy detection and treatment NEW YORK–(BUSINESS WIRE)–#biotech–The Food Allergy Fund (FAF) today convened scientists, investors, policymakers, and advocates at its annual Summit in New York City, unveiling advances that mark a pivotal shift in food allergy care: from delayed detection and … [Read more…]

Steel work marks a major construction milestone for the $1.2-billion healthcare facility. NORTH CHARLESTON, S.C.–(BUSINESS WIRE)–The Barton Malow | Edifice joint venture team has begun structural steel work at Roper St. Francis Healthcare’s future Roper Hospital campus in North Charleston, marking a pivotal milestone in the construction of the $1.2 billion facility. The start of … [Read more…]

Claude Cowork surfaces and collates scientific information from across the organization, from a single prompt Sapio Sciences connects Anthropic’s Claude Cowork to the Sapio Platform via Sapio Elain, giving scientists and project leaders a single conversational interface to search, query and collate data across their R&D organization. Claude Cowork works with Sapio Elain, the AI … [Read more…]

Revenue of $1.244 Billion Revenue Grew 9% as Reported and 6% on a Constant Currency1 Basis Compared to the First Quarter of 2025 GAAP Net Loss Attributable to Bausch + Lomb Corporation of $71 Million Adjusted EBITDA (non-GAAP)1 of $189 Million; Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)1 of $200 Million Raising Full-Year 2026 Revenue and … [Read more…]

Refined strategy and disciplined execution position Company to unlock value from its portfolio, which includes Celea Therapeutics’ Phase 3-ready deupirfenidone for idiopathic pulmonary fibrosis, Gallop Oncology’s clinically-validated LYT-200 for myeloid malignancies, and Seaport Therapeutics’ advancing clinical-stage pipeline for neuropsychiatric disorders PureTech level cash, cash equivalents and short-term investments of $277.1 million1 and Consolidated cash, cash … [Read more…]

HOUSTON–(BUSINESS WIRE)–TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, today announced a $150K pre-seed investment from Caduceus Capital Partners and its selection into the Caduceus LAUNCH digital health accelerator. The company has also opened a $1.5M round to accelerate growth. Founded by board-certified neurologist and clinical researcher Jontel Pierce, … [Read more…]

INCHEON, Korea & SHANGHAI–(BUSINESS WIRE)–#ATLATL–Samsung Bioepis Co., Ltd. and ATLATL Innovation Center (hereinafter referred to as “ATLATL”), global innovation platform for life science research and development, today announced that the companies have entered into a Memorandum of Understanding (MoU) on an open innovation program to accelerate early-stage biotech innovation in Asia-Pacific. Through this partnership, Samsung … [Read more…]

Procedures for obtaining preparatory documents for the General Meeting are described below. PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced that it will hold its Annual General Meeting on May 19, … [Read more…]